Werewolf Therapeutics reports Q3 results
Source: SeekingAlpha
2025-11-04 12:21:06 ET
More on Werewolf Therapeutics
- Seeking Alpha’s Quant Rating on Werewolf Therapeutics
- Historical earnings data for Werewolf Therapeutics
- Financial information for Werewolf Therapeutics
Read the full article on Seeking Alpha
For further details see:
Werewolf Therapeutics reports Q3 results
Werewolf Therapeutics Inc.
NASDAQ: HOWL
HOWL Trading
4.46% G/L:
$0.7207 Last:
164,319 Volume:
$0.7327 Open:
HOWL Latest News
February 24, 2026 04:09:32 pm
Werewolf Therapeutics Announces Plan to Explore Strategic Alternatives
HOWL Stock Data
$34,453,834
30,386,165
4.53%
17
N/A
Biotechnology & Life Sciences
Healthcare
US
Watertown
